Exact Mass: 476.1664
Exact Mass Matches: 476.1664
Found 500 metabolites which its exact mass value is equals to given mass value 476.1664
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate
1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate is found in herbs and spices. 1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate is a constituent of Myristica fragrans (nutmeg). Constituent of Myristica fragrans (nutmeg). 1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate is found in herbs and spices.
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain Temocapril belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Bapta
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
Vemlidy
Matteucinol 7-O-glucoside
7,8-trans-8,8-trans-7,8-cis-7-(5-methoxy-3,4-methylenedioxyphenyl)-7-(4-hydroxy3,5-dimethoxyphenyl)-8-acetoxymethyl-8-hydroxymethyltetrahydrofuran
1-[1-(2,4-dihydroxyphenyl)-9-(2-dimethylaminoethyl)-2-hydroxy-2,3-dihydro-1H-3a-azacyclopenta[a]inden-1-yl]benzene-3,4,5-triol|yuremamine
3,4,5-trimethoxyphenol D-apio-beta-D-furanosyl-(1->6)-beta-D-glucopyronoside
2-(4-hydroxyphenyl)ethyl 6-O-[(E)-feruloyl]-beta-D-glucopyranoside|grayanoside A
7,8-trans-8,8-trans-7,8-trans-7-(4-hydroxy-3,5-dimethoxyphenyl)-7-(5-methoxy-3,4-methylenedioxyphenyl)-8-acetoxymethyl-8-hydroxymethyltetrahydrofuran
(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside
arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside
5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester
4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone
(2R,3R)-6-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]pinobanksin 3-acetate
2-(3-hydroxy-4-methoxyphenyl)ethanol 1-O-[alpha-L-rhamnopiranosyl-(1?2)-beta-D-glucopyranoside]
(1S,5R,7S,8S,9S)-7-acetoxy-10-chloro-5-hydroxy-1,11-diisovaleroxy-5,6-dihydrovaltrate chlorohydrin|chlorovaltrate F
(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside
(10S)-10-C-(4-O-benzoyl-alpha-arabinopyranosyl)-1,8-dihydroxy-3-methylanthracen-9(10H)-one|picramnioside G
4-Me ether,3-O-alpha-L-rhamnopyranosyl-2-(3,4-Dihydroxyphenyl)ethyl beta-D-glucopy-ranoside
(2S,4R)-7,4-dihydroxy-6-methoxymethyl-8-methyl-4,2-oxidoflavan-5-O-beta-D-glucopyranoside|abacopterin G
2-methoxy-4-(1-hydroxyethyl)phenol 1-O-alpha-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
(-)-4-[beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranosyloxy]benzyl ethyl ether
Glu Asp Val Asp
Flunarizine 2HCl
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Flunarizine dihydrochloride is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine dihydrochloride is a D2 dopamine receptor antagonist. Flunarizine dihydrochloride shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate
C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester
C24H28O10_Spiro[furan-3(2H),1(4H)-naphthalene]-4a,5(5H)-dicarboxylic acid, 6-(acetyloxy)-5-(3-furanyl)-4,5,6,7,8,8a-hexahydro-5-hydroxy-2-methyl-2-oxo-, dimethyl ester
C21H32O12_Butanoic acid, 3-methyl-, (1aS,1bS,5S,5aS,6S,6aS)-2-[(beta-D-glucopyranosyloxy)methyl]-1a,1b,5,5a,6,6a-hexahydro-6-hydroxy-6-(hydroxymethyl)oxireno[3,4]cyclopenta[1,2-c]pyran-5-yl ester
[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]
[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate_major
[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate_53.3\\%
[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate_49.0\\%
Ala Cys Phe His
Ala Cys His Phe
Ala Glu Glu Glu
Ala Phe Cys His
Ala Phe His Cys
Ala His Cys Phe
Ala His Phe Cys
Cys Ala Phe His
Cys Ala His Phe
Cys Glu Glu Pro
Cys Glu Pro Glu
Cys Phe Ala His
Cys Phe His Ala
Cys His Ala Phe
Cys His Phe Ala
Cys His Met Ser
Cys His Ser Met
Cys Met His Ser
Cys Met Ser His
Cys Pro Glu Glu
Cys Ser His Met
Cys Ser Met His
Asp Asp Asp Ile
Asp Asp Asp Leu
Asp Asp Glu Val
Asp Asp Ile Asp
Asp Asp Leu Asp
Asp Asp Met Pro
Asp Asp Asn Asn
Asp Asp Pro Met
Asp Asp Val Glu
Asp Glu Asp Val
Asp Glu Val Asp
Asp Ile Asp Asp
Asp Leu Asp Asp
Asp Met Asp Pro
Asp Met Pro Asp
Asp Asn Asp Asn
Asp Asn Asn Asp
Asp Asn Gln Thr
Asp Asn Thr Gln
Asp Pro Asp Met
Asp Pro Met Asp
Asp Gln Asn Thr
Asp Gln Gln Ser
Asp Gln Ser Gln
Asp Gln Thr Asn
Asp Ser Gln Gln
Asp Thr Asn Gln
Asp Thr Gln Asn
Asp Val Asp Glu
Asp Val Glu Asp
Glu Ala Glu Glu
Glu Cys Glu Pro
Glu Cys Pro Glu
Glu Asp Asp Val
Glu Glu Ala Glu
Glu Glu Cys Pro
Glu Glu Glu Ala
Glu Glu Pro Cys
Glu Met Pro Thr
Glu Met Thr Pro
Glu Asn Asn Thr
Glu Asn Gln Ser
Glu Asn Ser Gln
Glu Asn Thr Asn
Glu Pro Cys Glu
Glu Pro Glu Cys
Glu Pro Met Thr
Glu Pro Thr Met
Glu Gln Asn Ser
Glu Gln Ser Asn
Glu Ser Asn Gln
Glu Ser Gln Asn
Glu Thr Met Pro
Glu Thr Asn Asn
Glu Thr Pro Met
Glu Val Asp Asp
Phe Ala Cys His
Phe Ala His Cys
Phe Cys Ala His
Phe Cys His Ala
Phe His Ala Cys
Phe His Cys Ala
His Ala Cys Phe
His Ala Phe Cys
His Cys Ala Phe
His Cys Phe Ala
His Cys Met Ser
His Cys Ser Met
His Phe Ala Cys
His Phe Cys Ala
His Met Cys Ser
His Met Ser Cys
His Ser Cys Met
His Ser Met Cys
Ile Asp Asp Asp
Leu Asp Asp Asp
Met Cys His Ser
Met Cys Ser His
Met Asp Asp Pro
Met Asp Pro Asp
Met Glu Pro Thr
Met Glu Thr Pro
Met His Cys Ser
Met His Ser Cys
Met Pro Asp Asp
Met Pro Glu Thr
Met Pro Thr Glu
Met Ser Cys His
Met Ser His Cys
Met Thr Glu Pro
Met Thr Pro Glu
Asn Asp Asp Asn
Asn Asp Asn Asp
Asn Asp Gln Thr
Asn Asp Thr Gln
Asn Glu Asn Thr
Asn Glu Gln Ser
Asn Glu Ser Gln
Asn Glu Thr Asn
Asn Asn Asp Asp
Asn Asn Glu Thr
Asn Asn Thr Glu
Asn Gln Asp Thr
Asn Gln Glu Ser
Asn Gln Ser Glu
Asn Gln Thr Asp
Asn Ser Glu Gln
Asn Ser Gln Glu
Asn Thr Asp Gln
Asn Thr Glu Asn
Asn Thr Asn Glu
Asn Thr Gln Asp
Pro Cys Glu Glu
Pro Asp Asp Met
Pro Asp Met Asp
Pro Glu Cys Glu
Pro Glu Glu Cys
Pro Glu Met Thr
Pro Glu Thr Met
Pro Met Asp Asp
Pro Met Glu Thr
Pro Met Thr Glu
Pro Thr Glu Met
Pro Thr Met Glu
Gln Asp Asn Thr
Gln Asp Gln Ser
Gln Asp Ser Gln
Gln Asp Thr Asn
Gln Glu Asn Ser
Gln Glu Ser Asn
Gln Asn Asp Thr
Gln Asn Glu Ser
Gln Asn Ser Glu
Gln Asn Thr Asp
Gln Gln Asp Ser
Gln Gln Ser Asp
Gln Ser Asp Gln
Gln Ser Glu Asn
Gln Ser Asn Glu
Gln Ser Gln Asp
Gln Thr Asp Asn
Gln Thr Asn Asp
Ser Cys His Met
Ser Cys Met His
Ser Asp Gln Gln
Ser Glu Asn Gln
Ser Glu Gln Asn
Ser His Cys Met
Ser His Met Cys
Ser Met Cys His
Ser Met His Cys
Ser Asn Glu Gln
Ser Asn Gln Glu
Ser Gln Asp Gln
Ser Gln Glu Asn
Ser Gln Asn Glu
Ser Gln Gln Asp
Thr Asp Asn Gln
Thr Asp Gln Asn
Thr Glu Met Pro
Thr Glu Asn Asn
Thr Glu Pro Met
Thr Met Glu Pro
Thr Met Pro Glu
Thr Asn Asp Gln
Thr Asn Glu Asn
Thr Asn Asn Glu
Thr Asn Gln Asp
Thr Pro Glu Met
Thr Pro Met Glu
Thr Gln Asp Asn
Thr Gln Asn Asp
Val Asp Asp Glu
Val Asp Glu Asp
Val Glu Asp Asp
1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate
Tenofovir alafenamide
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
Feclobuzone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Methotrexate sodium
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-[(4S)-7-cyano-3,4-dihydro-2H-chromen-4-yl]pyrrolidine-1-carboxamide
1-[2-Fluoro-3-[[6-methoxy-7-(phenylmethoxy)-4-quinolinyl]oxy]-6-nitrophenyl]-2-propanone
Bis[4-(3-aminophenoxy)phenyl] phenylphosphine oxide
1-[(6-Hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-(3,4,5-trimethoxyphenyl)methyl]-4-piperidinecarboxylic acid methyl ester
2-Ethoxybenzoic acid [5-methyl-4-(4-methylphenyl)sulfonyl-2-phenyl-3-pyrazolyl] ester
2-{5-[3-(7-Propyl-3-trifluoromethylbenzo[D]isoxazol-6-yloxy)propoxy]indol-1-YL}ethanoic acid
N-(Cyclopropylmethyl)-4-(methyloxy)-3-({5-[3-(3-pyridinyl)phenyl]-1,3-oxazol-2-YL}amino)benzenesulfonamide
N-{[2-({[1-(4-Carboxybutanoyl)amino]-2-phenylethyl}-hydroxyphosphinyl)oxy]acetyl}-2-phenylethylamine
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
Calcium Pantothenate
D - Dermatologicals > D03 - Preparations for treatment of wounds and ulcers > D03A - Cicatrizants A - Alimentary tract and metabolism > A11 - Vitamins D018977 - Micronutrients > D014815 - Vitamins
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
(2R)-3-[(9S, 9aR)-9-hydroxy-2,2-dimethyl-3-oxo-1H,2H,3H,9H,9aH-imidazolidino[1,2-a]indol-9-yl]-2-(2-acetyl-4-oxo-3,4-dihydroquinazolin-3-yl)propanoic acid
2-(2-Furanyl)-4-quinolinecarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester
4-[(3aR,4S,9bS)-8-[(4-methoxyphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]benzoic acid
Loniphenyruviridoside A, (rel)-
A natural product found in Lonicera japonica.
methyl 5-bromo-3-[[2-(4-cyclohexylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate
Guangsangon L
A member of the class of polyphenols consisting of a methylcyclohexene ring attached to a 2,4-dihydroxyphenyl, 2,4-dihydroxybenzoyl and 2,4-dihydroxybenzaldehyde moieties at positions 5, 4 and 3 respectively. Regarded biogenetically as a Diels-Alder adduct, it is isolated from the stem barks of Morus macroura and exhibits antioxidant activity.
N-(2,4-dimethoxyphenyl)-3-[[2-(2-methoxyphenoxy)-1-oxoethyl]amino]-2-benzofurancarboxamide
3-(2-chlorophenyl)-N-cyclohexyl-5-methyl-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-4-isoxazolecarboxamide
Ethyl 3-(2-chlorophenyl)-3-[(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)amino]propanoate
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(4-fluorophenyl)-2-(2-methoxyethyl)-1-oxo-3,4-dihydroisoquinoline-4-carboxamide
2-(2-Naphthalenylsulfonylamino)acetic acid [2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl] ester
methyl 2-[(3-amino-4-carbamoyl-5-cyclohexylimino-2H-thiophene-2-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(4-ethoxyphenyl)-N-[(E)-(4-propan-2-yloxyphenyl)methylideneamino]triazole-4-carboxamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(3S,6aS,8S,10aS)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
(1S,9R,10R,11R)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-12-(2-pyridin-2-ylacetyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-12-(2-pyridin-2-ylacetyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1S,9R,10R,11R)-N-ethyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-12-(pyridine-2-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(3R,6aS,8S,10aS)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(1R,9S,10S,11S)-N-ethyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-12-(pyridine-2-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(3aR,4R,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4R,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
[(3aS,4S,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-1-(pyridine-3-carbonyl)-N-(2,2,2-trifluoroethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-1-(pyridine-3-carbonyl)-N-(2,2,2-trifluoroethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(4S,4aR,5R,5aR,6S,11aS,12aR)-4-(dimethylamino)-1,5,6,10,11a,12a-hexahydroxy-6-methyl-3,11,12-trioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
BAPTA
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
5-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[7-hydroxy-5-methyl-4-oxo-2-(2-oxopropyl)chromen-8-yl]-6-(hydroxymethyl)oxan-3-yl (2e)-2-methylbut-2-enoate
[(1s,4as,5r,7as)-5-hydroxy-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-7-yl]methyl (2e)-3-phenylprop-2-enoate
(2r,3s)-2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
(2s,3's,3'ar,5'r,7'ar)-5'-[(1e)-5-(furan-3-yl)-2-methylpent-1-en-1-yl]-3',4,7'-trimethyl-5-oxo-1',2',3',3'a,5',7'a-hexahydrospiro[furan-2,4'-inden]-3-yloxidanesulfonic acid
4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid
5-[(1s,5r,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
2-(4-allyl-2,6-dihydroxyphenoxy)-1-(3,4-dihydroxyphenyl)-1-propanol; (r*,s*)-form,3,4-methylene,3',5'-di-me ether,benzoyl
{"Ingredient_id": "HBIN004285","Ingredient_name": "2-(4-allyl-2,6-dihydroxyphenoxy)-1-(3,4-dihydroxyphenyl)-1-propanol; (r*,s*)-form,3,4-methylene,3',5'-di-me ether,benzoyl","Alias": "NA","Ingredient_formula": "C28H28O7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9059","PubChem_id": "NA","DrugBank_id": "NA"}
(2R,3R,4S,5R,6S)-3-isopropyl-2-methylol-6-(phenoxy)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol
{"Ingredient_id": "HBIN006433","Ingredient_name": "(2R,3R,4S,5R,6S)-3-isopropyl-2-methylol-6-(phenoxy)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol","Alias": "(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-3-isopropyl-6-(phenoxy)-5-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]tetrahydropyran-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(phenoxy)-3-propan-2-yl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol; 134515-66-5; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-3-isopropyl-6-(phenoxy)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(phenoxy)-3-propan-2-yl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxane-3,4,5-triol","Ingredient_formula": "C21H32O12","Ingredient_Smile": "CC(C)C1(C(OC(C(C1O)(O)OC2C(C(C(C(O2)CO)O)O)O)OC3=CC=CC=C3)CO)O","Ingredient_weight": "476.47","OB_score": "3.006463945","CAS_id": "134515-66-5","SymMap_id": "SMIT10107","TCMID_id": "NA","TCMSP_id": "MOL008896","TCM_ID_id": "NA","PubChem_id": "179289","DrugBank_id": "NA"}
(2R,3 R)-6[1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl]-pinobanksin-3-acetate
{"Ingredient_id": "HBIN006448","Ingredient_name": "(2R,3 R)-6\uff3b1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl\uff3d-pinobanksin-3-acetate","Alias": "NA","Ingredient_formula": "C27H24O8","Ingredient_Smile": "CC(=O)OC1C(OC2=CC(=C(C(=C2C1=O)O)C(C=C)C3=CC(=C(C=C3)O)OC)O)C4=CC=CC=C4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41730","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
agrimonolide-6-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN014904","Ingredient_name": "agrimonolide-6-o-\u03b2-d-glucopyranoside","Alias": "MolPort-035-705-790; Aglimonolide 6-O-beta-D-glucoside; (3S)-8-HYDROXY-3-[2-(4-METHOXYPHENYL)ETHYL]-6-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}-3,4-DIHYDRO-2-BENZOPYRAN-1-ONE; Agrimonolide-6-O-glucopyranoside; Agrimonolide-6-O-beta-D-glucopyranoside; (3S)-8-hydroxy-3-[2-(4-methoxyphenyl)ethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroisochromen-1-one; DTXSID20155122; BG01759949; agrimonolide-6-o-beta-d-glucopyranoside; 1H-2-Benzopyran-1-one, 6-(beta-D-glucopyranosyloxy)-3,4-dihydro-8-hydroxy-3-(2-(4-methoxyphenyl)ethyl)-, (S)-; AC1L2Y67; W1312; C24H28O10; AKOS032948205; Agrimonolide 6-O-glucoside; ZINC31417663; A-6-GP; 126223-29-8","Ingredient_formula": "C24H28O10","Ingredient_Smile": "COC1=CC=C(C=C1)CCC2CC3=C(C(=CC(=C3)OC4C(C(C(C(O4)CO)O)O)O)O)C(=O)O2","Ingredient_weight": "476.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14193;SMIT19065","TCMID_id": "30117;761","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "133561827","DrugBank_id": "NA"}